Integrative Biomedical Research

Integrative Biomedical Research (Journal of Angiotherapy) | Online ISSN  3068-6326
463
Citations
1.8m
Views
768
Articles
Your new experience awaits. Try the new design now and help us make it even better
Switch to the new experience
REVIEWS   (Open Access)

Betty Fitriyasti 1* Md Abdur Rahman Biswash2, Md Abu Bakar Siddique3, Md Mostafizur Rahman3, Moushumi Afroza Mou3, Asim Debnath4

+ Author Affiliations

Integrative Biomedical Research 10 (1) 1-8 https://doi.org/10.25163/biomedical.10110919

Submitted: 20 November 2025 Revised: 12 January 2026  Accepted: 22 January 2026  Published: 24 January 2026 


Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) form a single clinicopathological spectrum united by the cytoplasmic mislocalisation and aggregation of RNA-binding proteins, most notably TDP-43 and FUS, alongside dipeptide-repeat proteins (DPRs) translated from the C9orf72 hexanucleotide expansion. A growing body of biophysical evidence indicates that these pathogenic assemblies do not arise directly from folded, native proteins but instead emerge from an intermediate, reversible state: liquid-liquid phase separation (LLPS). We conducted a narrative-structured synthesis of the primary biophysical literature on LLPS and the liquid-to-solid transition (LST) in ALS/FTD, drawing on in vitro reconstitution, coarse-grained molecular dynamics, nuclear magnetic resonance, single-molecule and cellular imaging studies of TDP-43, FUS, C9orf72-derived DPRs, TIA1, UBQLN2, and MATR3. Sequence-specific determinants-namely intrinsically disordered, low-complexity, and prion-like domains-govern the propensity of each protein to condense. TDP-43 phase separation depends on a conserved, transiently folding α-helix (residues 321-340), whose disruption by ALS mutations abolishes reversible LLPS and favours direct solid-state aggregation. FUS phase behaviour bifurcates according to mutation class, with arginine substitutions freezing static RNA contacts and glycine substitutions accelerating loss of fluidity. C9orf72 DPRs display divergent biophysical grammars: poly-GA undergoes hydrophobic homotypic demixing above a critical length of approximately fifty repeats, whereas arginine-rich poly-GR and poly-PR undergo heterotypic complex coacervation with polyanionic partners above roughly twenty-five repeats, closely matching clinical toxicity thresholds. Across systems, nucleation of amyloid fibrils is preferentially catalysed at the condensate-solvent interface, and chaperones such as Karyopherin-β2 and ubiquitin can reverse aberrant transitions. LLPS constitutes a mechanistic bridge between the genetics and neuropathology of ALS/FTD, and the biophysical rules identified here delineate concrete, druggable nodes-charge neutralisation, interface stabilisation, and chaperone enhancement-for future disease-modifying therapy.

Keywords: liquid–liquid phase separation; amyotrophic lateral sclerosis; frontotemporal dementia; TDP-43; FUS; C9orf72 dipeptide repeat proteins; liquid-to-solid transition

References

Alberti, C., Beckers, L., Boevin, M., Pfister, V., Gaucherot, A., Ruffenach, F., & Sellier, C. (2025). Autophagy-lysosome dysfunction and bidirectional RAN translation in C9orf72-associated ALS/FTD. Neurobiology of Disease, 217, 107192. https://doi.org/10.1016/j.nbd.2025.107192              

Alberti, S., Gladfelter, A., & Mittag, T. (2019). Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates. Cell, 176(3), 419–434. https://doi.org/10.1016/j.cell.2018.12.035      

Alberti, S., & Hyman, A. A. (2021). Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing. Nature Reviews Molecular Cell Biology, 22(3), 196–213. https://doi.org/10.1038/s41580-020-00326-6      

Alshareedah, I., Kaur, T., Ngo, J., Seppala, H., Kounatse, L. D., Wang, W., Moosa, M. M., & Banerjee, P. R. (2019). Interplay between short-range attraction and long-range repulsion controls reentrant liquid condensation of ribonucleoprotein-RNA complexes. Journal of the American Chemical Society, 141(37), 14593–14602. https://doi.org/10.1021/jacs.1c14593  

Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., & others. (2006). TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochemical and Biophysical Research Communications, 351(3), 602–611. https://doi.org/10.1016/j.bbrc.2006.02.049               

Asadi, M., Ivanov, P., & Wolozin, B. (2021). Stress granules in neurodegeneration: Core mechanisms and therapeutic targets. Frontiers in Cellular Neuroscience, 15, 664151. https://doi.org/10.3389/fncel.2021.664151           

Babazadeh, A., Rayner, S. L., Lee, A., & Chung, R. S. (2023). TDP-43 as a therapeutic target in neurodegenerative diseases: Focusing on motor neuron disease and frontotemporal dementia. Ageing Research Reviews, 92, 102085. https://doi.org/10.1016/j.arr.2023.102085

Babinchak, W. M., Haider, R., Dumm, B. K., Sarkar, P., Surewicz, K., Choi, J.-K., & Surewicz, W. K. (2019). The role of liquid–liquid phase separation in aggregation of the TDP-43 low-complexity domain. Journal of Biological Chemistry, 294(16), 6279–6289. https://doi.org/10.1074/jbc.RA118.007222

Boeynaems, S., Bogaert, E., Kovacs, D., Konijnenberg, A., Timmerman, E., Volkov, A., Guharoy, M., De Decker, M., Jaspers, T., Ryan, V. H., Janke, A. M., Baatsen, P., Vercruysse, T., Kolaitis, R. M., Daelemans, D., Taylor, J. P., Kedersha, N., Anderson, P., Impens, F., … Van Den Bosch, L. (2017). Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics. Molecular Cell, 65(6), 1044–1055. https://doi.org/10.1016/j.molcel.2017.02.013

Brangwynne, C. P., Eckmann, C. R., Courson, D. S., Rybarska, A., Hoege, C., Gharakhani, J., Jülicher, F., & Hyman, A. A. (2009). Germline P granules are liquid droplets that localize by controlled dissolution/condensation. Science, 324(5935), 1729–1732. https://doi.org/10.1126/science.1172046  

Cha, S. J., Lee, S., Choi, H.-J., Han, Y. J., Jeon, Y.-M., Jo, M., & Kim, K. (2022). Therapeutic modulation of GSTO activity rescues FUS-associated neurotoxicity via deglutathionylation in ALS disease models. Developmental Cell, 57(6), 783–798. https://doi.org/10.1016/j.devcel.2022.02.022           

Chang, Y. J., Jeng, U. S., Chen, Y. R., & others. (2016). The glycine-alanine dipeptide repeat from C9orf72 hexanucleotide expansions forms toxic amyloids possessing cell-to-cell transmission properties. Journal of Biological Chemistry, 291(9), 4903–4911. https://doi.org/10.1074/jbc.M115.692891 

Clark, D. G. (2024). Frontotemporal dementia. Continuum (Minneapolis, Minn.), 30(6), 1642–1672. https://doi.org/10.1212/CON.0000000000001506  

Conicella, A. E., Zerze, G. H., Mittal, J., & Fawzi, N. L. (2016). ALS mutations disrupt phase separation mediated by α-helical structure in the TDP-43 low-complexity C-terminal domain. Structure, 24(9), 1537–1549. https://doi.org/10.1016/j.str.2016.07.007 

Dao, T. P., Kolaitis, R.-M., Kim, H. J., O'Donovan, K., Martyniak, B., Colicino, E., Hehnly, H., Taylor, J. P., & Castañeda, C. A. (2018). Ubiquitin modulates liquid-liquid phase separation of UBQLN2 via disruption of multivalent interactions. Molecular Cell, 69(6), 965–978. https://doi.org/10.1016/j.molcel.2018.03.012 

Dao, T. P., Martyniak, B., Colicino, E. G., Cosgrove, M. S., Hehnly, H., Castañeda, C. A., & others. (2019). ALS-linked mutations affect UBQLN2 oligomerization and phase separation in a position- and amino acid-dependent manner. Structure, 27(6), 937–951. https://doi.org/10.1016/j.str.2019.03.012  

Das, S., Lin, Y. H., Vernon, R. M., Forman-Kay, J. D., & Chan, H. S. (2020). Comparative roles of charge, π, and hydrophobic interactions in sequence-dependent phase separation of intrinsically disordered proteins. Proceedings of the National Academy of Sciences, 117(46), 28795–28805. https://doi.org/10.1073/pnas.2008712117

DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., & others. (2011). Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron, 72(2), 245–256. https://doi.org/10.1016/j.neuron.2011.09.011       

de La Seiglière, H., Letourneur, Æ., Ichas, F., & De Giorgi, F. (2026). Phase separation and protein aggregation in neurodegenerative diseases. Biophysical Chemistry, 338, 107678. https://doi.org/10.1016/j.bpc.2026.107678            

Djaja, N. A., Chang, M. T., Beinart, F. R., Morris, V. M., Ganser, L. R., & Myong, S. (2023). Nucleation and dissolution mechanism underlying amyotrophic lateral sclerosis/frontotemporal lobar dementia-linked fused in sarcoma condensates. iScience, 26(4), 106537. https://doi.org/10.1016/j.isci.2023.106537

Fay, M. M., Anderson, P. J., & Ivanov, P. (2017). ALS/FTD-associated C9ORF72 repeat RNA promotes phase transitions in vitro and in cells. Cell Reports, 21(12), 3573–3584. https://doi.org/10.1016/j.celrep.2017.11.093     

Freibaum, B. D., Lu, Y., Lopez-Gonzalez, R., Kim, N. C., Almeida, S., Lee, K. H., & others. (2015). GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature, 525(7567), 129–133. https://doi.org/10.1038/nature14973    

Gao, C., Gu, J., Zhang, H., Liu, C., Dai, B., & Song, J. (2022). Hyperosmotic-stress-induced liquid-liquid phase separation of ALS-related proteins in the nucleus. Cell Reports, 40(3), 111086. https://doi.org/10.1016/j.celrep.2022.111086            

Gendron, T. F., Bieniek, K. F., & Petrucelli, L. (2013). Antisense transcripts of the expanded C9ORF72 hexanucleotide                repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathologica, 126, 829–844. https://doi.org/10.1007/s00401-013-1174-y            

Ghanbari Niaki, A., Sarkar, J., Cai, X., Rhine, K., Vidaurre, V., Guy, B., Hurst, M., Lee, J. C., Koh, H. R., Guo, L., Fare, C. M., Shorter, J., & Myong, S. (2020). Loss of dynamic RNA interaction and aberrant phase separation induced by two distinct types of ALS/FTD-linked FUS mutations. Molecular Cell, 77(1), 82–94. https://doi.org/10.1016/j.molcel.2019.09.022          

Gittings, L. M., Smikle, R., Reid, M. J., Solomon, D. A., & Mizielinska, S. (2020). Symmetric dimethylation of poly-GR correlates with disease duration in C9orf72 FTLD and ALS and reduces poly-GR phase separation and toxicity. Acta Neuropathologica, 139(2), 407–410. https://doi.org/10.1007/s00401-019-02102-1 

Gomes, E., & Shorter, J. (2019). The molecular language of membraneless organelles. Journal of Biological Chemistry, 294(18), 7115–7127. https://doi.org/10.1074/jbc.REV119.007944 

Guo, L., Kim, H. J., Wang, H., Monaghan, J., Freyermuth, F., Sung, J. C., O'Donovan, K., Fare, C. M., Diaz, Z., Singh, N., & others. (2018). Nuclear-import receptors reverse aberrant phase transitions of RNA-binding proteins with prion-like domains. Cell, 173(3), 677–692. https://doi.org/10.1016/j.cell.2018.03.002       

Hofmann, H., Soranno, A., & Schuler, B. (2012). Polymer scaling laws of unfolded and intrinsically disordered proteins quantified with single-molecule spectroscopy. Proceedings of the National Academy of Sciences, 109(40), 16155–16160. https://doi.org/10.1073/pnas.1216155109

Ishiguro, A., Katayama, A., & Ishihama, A. (2021). Different recognition modes of G-quadruplex RNA between two ALS/FTLD-linked proteins TDP-43 and FUS. FEBS Letters, 595(3), 310–323. https://doi.org/10.1002/1873-3468.14021       

Ito, D., & Suzuki, N. (2011). Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS. Neurology, 77(17), 1636–1643. https://doi.org/10.1212/WNL.0b013e318234a5bd        

Jafarinia, H., van der Giessen, E., & Onck, P. R. (2020). Phase separation of toxic dipeptide repeat proteins related to C9orf72 ALS/FTD. Biophysical Journal, 119(4), 843–851. https://doi.org/10.1016/j.bpj.2020.07.005            

Kanekura, K., & Kuroda, M. (2022). How can we interpret the relationship between liquid-liquid phase separation and amyotrophic lateral sclerosis? Laboratory Investigation, 102(9), 912–918. https://doi.org/10.1038/s41374-022-00791-x            

Kato, M., Han, T. W., Xie, S., Shi, K., Du, X., Wu, L. C., & McKnight, S. L. (2012). Cell-free formation of RNA granules: Low complexity sequence domains form dynamic fibers within hydrogels. Cell, 149(4), 753–767. https://doi.org/10.1016/j.cell.2012.04.017

Khosravi, B., Hartmann, H., May, S., Hornburg, D., Edbauer, D., & others. (2017). Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS/FTLD. Human Molecular Genetics, 26(4), 790–800. https://doi.org/10.1093/hmg/ddw432

King, O. D., Gitler, A. D., & Shorter, J. (2012). The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Research, 1462, 61–80. https://doi.org/10.1016/j.brainres.2012.01.016

Lee, K. H., Zhang, P., Kim, H. J., Mitrea, D. M., Sarkar, M., Freibaum, B. D., & others. (2016). C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell, 167(3), 774–788. https://doi.org/10.1016/j.cell.2016.09.017               

Lee, S., Kim, H.-J., & Kim, K. (2022). Glutathionylation of FUS regulates its liquid-liquid phase separation and pathological aggregation under oxidative stress. Developmental Cell, 57(6), 783–798. https://doi.org/10.1016/j.devcel.2022.02.022

Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013). Converging mechanisms in ALS and FTD: Disrupted RNA and protein homeostasis. Neuron, 79(3), 416–438. https://doi.org/10.1016/j.neuron.2013.07.030    

Linsenmeier, M., Faltova, L., Morelli, C., Capasso Palmiero, U., Seiffert, C., Küffner, A. M., & Arosio, P. (2023). The interface of condensates of the hnRNPA1 low-complexity domain promotes formation of amyloid fibrils. Nature Chemistry, 15(10), 1340–1349. https://doi.org/10.1038/s41557-023-01289-9          

Mackenzie, I. R., Nicholson, A. M., Sarkar, M., Messing, J., Purice, M. D., Pottier, C., Annu, K., Baker, M., Perkerson, R. B., Kurti, A., Matchett, B. J., Mittag, T., Temirov, J., Hsiung, G. R., Krieger, C., Murray, M. E., Kato, M., Fryer, J. D., Petrucelli, L., … Rademakers, R. (2017). TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics. Neuron, 95(4), 808–816. https://doi.org/10.1016/j.neuron.2017.07.025          

Maor-Nof, M., Shipony, Z., Lopez-Gonzalez, R., Wu, L., Bastian, M. P., & others. (2021). p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR). Cell, 184(3), 689–708. https://doi.org/10.1016/j.cell.2020.12.025

Masrori, P., & Van Damme, P. (2020). Amyotrophic lateral sclerosis: A clinical review. European Journal of Neurology, 27(10), 1918–1929. https://doi.org/10.1111/ene.14393   

Mompeán, M., Romano, V., Pantoja-Uceda, D., Stuani, C., Baralle, F. E., Buratti, E., & Laurents, D. V. (2016). The TDP-43 N-terminal domain structure at high resolution. FEBS Journal, 283(7), 1242–1260. https://doi.org/10.1111/febs.13653            

Mori, K., Weng, S. M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Van Broeckhoven, C., & others. (2013). The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science, 339(6125), 1335–1338. https://doi.org/10.1126/science.1231037      

Nanaura, H., Shinkai, Y., Tokunaga, S., & others. (2021). C9orf72-derived arginine-rich poly-dipeptides impede phase modifiers. Nature Communications, 12, 5301. https://doi.org/10.1038/s41467-021-25601-w          

Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., & Lee, V. M. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314(5797), 130–133. https://doi.org/10.1126/science.1134108  

Nott, T. J., Petsalaki, E., Farber, P., Jervis, D., Fussner, E., Plochowietz, A., Craggs, T. D., Bazett-Jones, D. P., Pawson, T., Forman-Kay, J. D., & Baldwin, A. J. (2015). Phase transition of a disordered nuage protein generates environmentally responsive membraneless organelles. Molecular Cell, 57(5), 936–947. https://doi.org/10.1016/j.molcel.2015.01.013

Olney, N. T., Spina, S., & Miller, B. L. (2017). Frontotemporal dementia. Neurologic Clinics, 35(2), 339–374. https://doi.org/10.1016/j.ncl.2017.01.008 

Patel, A., Lee, H. O., Jawerth, L., Maharana, S., Jahnel, M., Hein, M. Y., Stoynov, S., Mahamid, J., Saha, S., Franzmann, T. M., Pozniakovski, A., Poser, I., Maghelli, N., Royer, L. A., Weigert, M., & others. (2015). A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell, 162(5), 1066–1077. https://doi.org/10.1016/j.cell.2015.07.047       

Pérez-Berlanga, M., Wiersma, V. I., Zbinden, A., De Vos, L., Wagner, U., Foglieni, C., & Polymenidou, M. (2023). Loss of RNA function in ALS/FTD-associated protein aggregation. Cell Reports, 42(1), 111990. https://doi.org/10.1016/j.celrep.2022.111990           

Raguseo, F., Wang, Y., Li, J., Petric Howe, M., Balendra, R., Huyghebaert, A., & Di Antonio, M. (2023). The ALS/FTD-related C9orf72 hexanucleotide repeat expansion forms RNA condensates through multimolecular G-quadruplexes. Nature Communications, 14(1), 8272. https://doi.org/10.1038/s41467-023-44111-y

Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., & others. (2011). A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron, 72(2), 257–268. https://doi.org/10.1016/j.neuron.2011.09.010            

Ryan, V. H., Dignon, G. L., Zerze, G. H., Chabata, C. V., Silva, R., Conicella, A. E., Amaya, J., Burke, K. A., Mittal, J., & Fawzi, N. L. (2018). Mechanistic view of hnRNPA2 low-complexity domain structure, interactions, and phase separation altered by mutation and arginine methylation. Molecular Cell, 69(3), 465–479. https://doi.org/10.1016/j.molcel.2018.01.037          

Shorter, J. (2019). Phase separation of RNA-binding proteins in physiology and disease: An introduction to the JBC Reviews thematic series. Journal of Biological Chemistry, 294(18), 7115–7127. https://doi.org/10.1074/jbc.REV119.007944

Snowden, J. S., Rollinson, S., Thompson, J. C., Harris, J. M., Adams, J., Jones, M., & Pickering-Brown, S. M. (2012). Distinct clinical and pathological phenotypes in frontotemporal dementia associated with hexanucleotide repeat expansion in C9orf72: A cross-sectional study. The Lancet Neurology, 11(4), 323–330. https://doi.org/10.1016/S1474-4422(12)70043-1

Sprunger, M. L., Jackrel, M. E., & Pappu, R. V. (2025). Multivalent interactions and RNA binding modulate MATR3 nanoscale spherical and wormlike assemblies. Molecular Cell, 85(19), 3640–3660. https://doi.org/10.1016/j.molcel.2025.08.034           

Van Langenhove, T., van der Zee, J., & Van Broeckhoven, C. (2012). The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum. Annals of Medicine, 44(8), 817–828. https://doi.org/10.3109/07853890.2012.665484               

Visser, B. S., van Haren, M. H. I., Lipinski, W. P., van Leijenhorst-Groener, K. A., Claessens, M. M. A. E., Queirós, M. V. A., & Spruijt, E. (2025). Controlling interfacial protein adsorption, desorption and aggregation in biomolecular condensates. Nature Communications, 16(1), 10172. https://doi.org/10.1038/s41467-025-65030-5

Wang, J., Choi, J. M., Holehouse, A. S., Lee, H. O., Zhang, X., Jahnel, M., Maharana, S., Lemaitre, R., Pozniakovsky, A., Drechsel, D., Poser, I., Pappu, R. V., Alberti, S., & Hyman, A. A. (2018). A molecular grammar governing the driving forces for phase separation of prion-like RNA binding proteins. Cell, 174(3), 688–699. https://doi.org/10.1016/j.cell.2018.03.004       

Wegmann, S., Eftekharzadeh, B., Tepper, K., Zoltowska, K. M., Bennett, R. E., Dujardin, S., Laskowski, P. R., MacKenzie, D., Kamath, T., Commins, C., Vanderburg, C., Roe, A. D., Fan, Z., Molliex, A. M., Hernandez-Vega, A., & others. (2018). Tau protein liquid–liquid phase separation can initiate tau aggregation. The EMBO Journal, 37(7), e98049. https://doi.org/10.15252/embj.201798049          

White, M. R., Mitrea, D. M., & Kriwacki, R. W. (2019). C9orf72 poly(PR) dipeptide repeats disturb biomolecular phase separation and disrupt nucleolar function. Molecular Cell, 74(4), 713–728. https://doi.org/10.1016/j.molcel.2019.03.018

Wolozin, B., & Ivanov, P. (2019). Stress granules and neurodegeneration. Nature Reviews Neuroscience, 20(11), 649–666. https://doi.org/10.1038/s41583-019-0222-7            

Zhang, Y. J., Gendron, T. F., Ebbert, M. T. W., O'Raw, A. D., Yue, M., Jansen-West, K., & others. (2016). C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nature Neuroscience, 19(5), 668–677. https://doi.org/10.1038/nn.4272  


Article metrics
View details
0
Downloads
0
Citations
34
Views

View Dimensions


View Plumx


View Altmetric



0
Save
0
Citation
34
View
0
Share